A PRP injection for knee arthritis is a procedure that concentrates platelets from a patient’s own blood and injects them into the knee joint, with the aim of reducing pain and improving function. PRP sits in a different category from most knee arthritis treatments, because the evidence behind it is still developing and insurance rarely pays for it. This article covers how PRP is prepared, what the research currently supports, who tends to be considered a candidate, and what actually drives the cost.
How Is PRP Prepared for a Knee Injection?
PRP preparation starts with a standard blood draw, usually from the arm. The sample is placed in a centrifuge that spins it at high speed, separating red blood cells from plasma and concentrating the platelets into a small volume. That concentrate is then injected into the knee joint, often with ultrasound or landmark guidance, in the same visit.
Preparation is not standardized across practices, and the differences matter more than most patients realize:
- Platelet concentration. Different systems produce different platelet counts, and there is no single agreed target.
- Leukocyte content. Leukocyte-rich and leukocyte-poor preparations contain different amounts of white blood cells, and the two are studied as distinct products.
- Volume and injection number. Some protocols use one injection, others use a series spaced weeks apart.
- Activation method. Some protocols activate the platelets before injection, others rely on activation within the joint.
Because these variables differ between studies, results from one trial do not automatically apply to the preparation used somewhere else. Dr. Steven J. Thornton evaluates whether biologic therapies including PRP are appropriate for a given patient as part of a broader treatment discussion.
How Is PRP Thought to Work Inside an Arthritic Knee?
PRP is thought to act on the inflammatory environment of the joint rather than on the structure of the cartilage itself. Platelets carry growth factors and signaling proteins, and the working theory is that concentrating them in the joint may influence inflammation and the behavior of the cells lining the joint.
What PRP is not established to do is equally important. Current evidence does not support the claim that a PRP injection regenerates lost cartilage or reverses arthritis, and patients should be cautious about any description that promises it will. The realistic framing is symptom management in a joint that has structural changes which remain present after treatment.
Regulatory status is often misunderstood. PRP itself is not FDA approved as a treatment for knee arthritis. The centrifuge systems used to prepare it are FDA cleared for preparing a platelet concentrate, which is a statement about the equipment rather than an endorsement of any clinical indication, and physicians use the resulting product off-label under the practice of medicine.
What Does the Evidence Show for PRP in Knee Arthritis?
The evidence for PRP in knee arthritis is mixed rather than settled, and that is the honest summary as of now. Some randomized trials and meta-analyses have reported improvements in pain and function compared with saline or hyaluronic acid, particularly in earlier-stage arthritis. Other high-quality placebo-controlled trials have not reproduced those results over longer follow-up.
Two points define the current state of the research:
- High-quality placebo-controlled trials have shown inconsistent long-term benefit, with some finding no advantage over saline beyond six to twelve months, which is why professional bodies have stopped short of a strong endorsement.
- Nonarthroplasty guidance for knee osteoarthritis has called for better research into platelet-rich plasma, including full characterization of the preparation and stratification by arthritis severity, reflecting how much the products and protocols vary between studies.
On safety, the picture is more consistent. Because PRP is made from the patient’s own blood, reported adverse events across studies have been relatively few, though the procedure still carries the risks of any joint injection, including infection, bleeding, and a temporary increase in pain and swelling after the injection.
Which Patients Are Considered for PRP?
Candidacy for PRP in knee arthritis is generally discussed for patients with mild to moderate arthritis who still have joint space remaining, rather than for advanced disease where the cartilage surfaces are largely gone. Selection is individual, and no single factor decides it.
Factors that typically enter the discussion:
- Arthritis grade on imaging. Earlier-stage changes are where the research is most encouraging. Advanced arthritis with bone-on-bone contact is generally not where PRP is expected to help.
- Symptom pattern. Pain with activity in a knee that still moves reasonably well is different from a stiff, deformed, mechanically failing joint.
- What has already been tried. PRP is usually considered after activity modification, weight management where relevant, physical therapy, and often after a trial of other injections.
- Age and activity level. Younger and active patients hoping to delay a knee replacement are a common group to raise the question, though age alone does not determine candidacy.
- Tolerance for uncertainty and out-of-pocket cost. PRP is an elective, self-funded decision for most patients, which belongs in the conversation from the start.
How Does PRP Compare With Cortisone, Hyaluronic Acid, and Surgery?
PRP, cortisone, hyaluronic acid, and surgery address knee arthritis at different points and are not interchangeable. Cortisone and hyaluronic acid have longer track records and broader insurance coverage; PRP has a shorter and less consistent evidence base, and surgery addresses structural problems the injections cannot.
| Option | Intended effect | Typical role | Insurance coverage |
|---|---|---|---|
| Corticosteroid injection | Reduces inflammation in the joint | Often used first for a symptom flare, with relief that tends to be shorter term | Commonly covered |
| Hyaluronic acid injection | Supplements the lubricating fluid in the joint | Used in some patients with mild to moderate arthritis, coverage rules vary by payer | Often covered with conditions |
| PRP injection | Aims to modify the inflammatory environment using concentrated platelets | Considered mainly in mild to moderate arthritis, usually after other measures | Generally not covered |
| Knee replacement or other surgery | Addresses the structural problem directly | Considered for advanced arthritis when nonsurgical care no longer works | Covered when medically indicated |
The sequence matters more than the ranking. Most patients work through nonsurgical options before surgery is considered, and where PRP fits in that sequence depends on the individual knee, the imaging, and what has already failed.
What Determines the Cost of a PRP Injection?
PRP for knee arthritis is generally not covered by insurance, because most payers classify it as investigational for this indication, so patients should plan for an out-of-pocket cost. That status can change as evidence develops, and it is worth confirming with your own plan rather than assuming.
Factors that drive the price:
- Number of injections in the protocol. A single injection and a three-injection series are priced very differently.
- Preparation system used. Higher-yield systems and single-use kits cost the practice more.
- Image guidance. Ultrasound-guided injection may be billed separately.
- Facility setting. An office procedure and a procedure performed at a surgical facility carry different overhead.
- Whether the consultation and imaging are separate. The evaluation that determines candidacy is often billed on its own, and that portion may be covered.
Ask for the total cost of the full protocol in writing before scheduling, not the price of a single injection, and ask what happens if the first injection does not help. Steven Thornton, MD, reviews cost, expected follow-up, and individual response as part of deciding whether biologic therapy is appropriate.
Frequently Asked Questions
No. PRP is not FDA approved as a treatment for knee arthritis. The centrifuge systems used to prepare PRP are FDA cleared for producing a platelet concentrate, which concerns the equipment rather than any clinical indication. Physicians use the resulting product off-label under the practice of medicine.
Current evidence does not establish that PRP regenerates lost cartilage or reverses arthritis. The working theory involves influencing inflammation within the joint rather than rebuilding the joint surface. Any structural changes present before the injection remain present afterward, so PRP is discussed as symptom management.
Protocols vary. Some practices use a single injection, others use a series of two or three spaced weeks apart, and the research has not settled which approach works best. Ask which protocol is planned, how many injections it includes, and what the total cost covers before starting.
Insurance generally does not cover PRP for knee arthritis, since most payers classify it as investigational for this use. The consultation and any imaging may still be covered separately. Coverage policies change over time, so verify with your specific plan rather than relying on general guidance.
Research has not established one as the right choice in all cases. Cortisone has a longer track record and broader coverage, while PRP has a shorter and less consistent evidence base. Which is more appropriate depends on your arthritis stage, what you have already tried, and your goals, which requires an evaluation.
Reported duration varies widely across studies and patients, and some trials have found benefit fading between six and twelve months. Others report no meaningful difference from placebo at longer follow-up. No reliable duration can be promised in advance, which is part of the trade-off patients weigh.
Deciding Whether PRP Fits Your Knee Arthritis
PRP for knee arthritis is a reasonable question to raise with a specialist, and it is best approached with clear expectations about what the evidence does and does not currently support. Bring your imaging, a list of what you have already tried, and your questions about cost, and expect a conversation about whether PRP, another injection, continued nonsurgical care, or surgery best fits the stage of your arthritis.
Patients across the Dallas-Fort Worth metroplex can request a consultation with Dr. Steven J. Thornton at Texas Orthopaedic Associates to review the options for an arthritic knee. His fellowship training and surgical background cover both biologic and surgical approaches, and his practice also treats shoulder, hip, and elbow conditions.
Written by:
Dr. Steven J. Thornton, MD, is a board-certified orthopedic surgeon and fellowship-trained sports medicine specialist who founded his Dallas practice in 2004 and is part of Texas Orthopaedic Associates. He completed his medical education at the University of Mississippi School of Medicine, his residency at UT Southwestern Medical Center, and his fellowship at Cornell University’s Hospital for Special Surgery. Dr. Thornton treats shoulder, knee, hip, and elbow conditions with a focus on arthroscopic and minimally invasive surgical techniques.